FDA gives full approval to Novavax COVID shot for high-risk groups

The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup